[{"id": 320, "label": "SUPPORT", "claim": "Deficiency of Tetraspanin-3 causes impaired stem cell-renewal and disease propagation.", "response": "Predicates:\nDeficiency(Tetraspanin-3) ::: Verify the deficiency of Tetraspanin-3.\nImpaired(Deficiency of Tetraspanin-3, stem cell-renewal) ::: Verify if the deficiency of Tetraspanin-3 causes impaired stem cell-renewal.\nPropagate(Deficiency of Tetraspanin-3, disease) ::: Verify if the deficiency of Tetraspanin-3 causes disease propagation.\n\nFollowup Question: What causes impaired stem cell-renewal?\nFollowup Question: Does the deficiency of Tetraspanin-3 cause disease propagation?"}, {"id": 33, "label": "CONTRADICT", "claim": "A deficiency of folate decreases blood levels of homocysteine.", "response": "Predicates:\nDeficiency(folate) ::: Verify that there is a deficiency of folate.\nDecrease(blood levels of homocysteine) ::: Verify that the deficiency of folate decreases blood levels of homocysteine.\n\nFollowup Question: What happens if there is a deficiency of folate?\nFollowup Question: How does a deficiency of folate affect blood levels of homocysteine?"}, {"id": 664, "label": "CONTRADICT", "claim": "KLF4 prevents VSMCs from acquiring genetic characteristics of other cell types within atherosclerotic lesions.", "response": "Predicates:\nPrevent(KLF4, VSMCs from acquiring genetic characteristics of other cell types within atherosclerotic lesions) ::: Verify that KLF4 prevents VSMCs from acquiring genetic characteristics of other cell types within atherosclerotic lesions.\n\nFollowup Question: What does KLF4 prevent VSMCs from acquiring within atherosclerotic lesions?"}, {"id": 1076, "label": "CONTRADICT", "claim": "Serotonin receptors have no effect on depression", "response": "Predicates:\nEffect(Serotonin receptors, depression) ::: Verify the effect of serotonin receptors on depression.\n\nFollowup Question: What is the effect of serotonin receptors on depression?"}, {"id": 931, "label": "SUPPORT", "claim": "Patients with panic anxiety show increased CSF levels of hypocretin.", "response": "Predicates:\nCondition(Patients, panic anxiety) ::: Verify that patients have panic anxiety.\nIncreasedLevels(Patients, CSF levels of hypocretin) ::: Verify that patients show increased CSF levels of hypocretin.\n\nFollowup Question: What condition do patients have?\nFollowup Question: What are the increased levels in patients with panic anxiety?"}, {"id": 1108, "label": "SUPPORT", "claim": "Suboptimal nutrition is a leading cause of chronic disease", "response": "Predicates:\nCause(Suboptimal nutrition, chronic disease) ::: Verify that suboptimal nutrition is a leading cause of chronic disease.\n\nFollowup Question: What is a leading cause of chronic disease?"}, {"id": 1233, "label": "CONTRADICT", "claim": "The minor G allele of FOXO3 represses IL-10.", "response": "Predicates:\nAllele(FOXO3, G) ::: Verify FOXO3 has the minor G allele.\nRepresses(FOXO3, IL-10) ::: Verify the minor G allele of FOXO3 represses IL-10.\n\nFollowup Question: What allele does FOXO3 have?\nFollowup Question: What does the minor G allele of FOXO3 repress?"}, {"id": 240, "label": "CONTRADICT", "claim": "Cellular aging is uncorrelated with an older appearance.", "response": "Predicates:\nUncorrelated(Cellular aging, an older appearance) ::: Verify that cellular aging is uncorrelated with an older appearance.\n\nFollowup Question: Is cellular aging correlated with a younger appearance?"}, {"id": 276, "label": "CONTRADICT", "claim": "Combining phosphatidylinositide 3-kinase and MEK 1/2 inhibitors is ineffective at treating KRAS mutant tumors.", "response": "Predicates:\nTreatment(phosphatidylinositide 3-kinase and MEK 1/2 inhibitors, KRAS mutant tumors) ::: Verify the effectiveness of combining phosphatidylinositide 3-kinase and MEK 1/2 inhibitors in treating KRAS mutant tumors.\n\nFollowup Question: Is the combination of phosphatidylinositide 3-kinase and MEK 1/2 inhibitors effective in treating KRAS mutant tumors?"}, {"id": 150, "label": "SUPPORT", "claim": "Autophagy deficiency in the liver protects from insulin resistance.", "response": "Predicates:\nDeficiency(Autophagy, in the liver) ::: Verify there is a deficiency of autophagy in the liver.\nProtects(from insulin resistance) ::: Verify that protection from insulin resistance is provided by autophagy deficiency in the liver.\n\nFollowup Question: What is the impact of autophagy deficiency in the liver?\nFollowup Question: How does autophagy deficiency in the liver relate to insulin resistance?"}]